Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 4, 2001, Pages 538-540

  Porta, M ^a   Gamba, M ^a   Bertacchi, G ^a   Vaj, P ^a  

^a Pain Centre   (Italy)

Author keywords

Botulinum toxin type A; Neurological diseases; Sialorrhoea; Ultrasound

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN INJURY; CEREBRAL PALSY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; FEMALE; HUMAN; HYPERSALIVATION; INJECTION SITE; MALE; PARKINSON DISEASE; PAROTID GLAND; PRIORITY JOURNAL; SUBACUTE SCLEROSING PANENCEPHALITIS; SUBMANDIBULAR GLAND; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; HUMANS; MIDDLE AGED; NERVOUS SYSTEM DISEASES; SIALORRHEA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0035059822     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.4.538     Document Type: Article

References (13)

1. Smith RA, Goode RL. Current concepts: sialorrhoea. N Engl J Med 1970;283:917-18.
2. Lew KM, Younis RT, Lazar RH. The current management of sialorrhea. Ear Nose Throat J 1991;70:99-105.
3. O'Dwyer TP, Conlon BJ. The surgical management of drooling: a 15 year follow up. Clin Otolaryngol 1997;22: 284-7.
4. Borg M, Hirst F. The role of radiation therapy in the management of sialorrhoea. Int J Radiat Oncol Biol Phys 1998; 41:1113-19.
5. O'Brien CF. Clinical applications of botulinum toxin: implications for pain management. Pain Dig 1998;8:342-5.
6. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990;53:633-9.
7. Naver H, Aquilonius S-M. The treatment of focal hyperhidrosis with botulinum toxin. Eur J Neurol 1997;4(suppl 2):S75-9.
8. Bushara KO. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment - botulinum toxin A injections of the parotid glands. Med Hypotheses 1997;48: 337-9.
9. Pal PK, Calne DB, Calne S, et al. Botulinum toxin A as treatment for drooling saliva in PD. Neurology 2000;54: 244-7.
10. Bhatia KP, Munchau A, Brown P. Botulinum toxin is a useful treatment in excessive drooling of saliva [letter]. J Neurol Neurosurg Psychiatry 1999;67:697.
11. Koman LA, Mooney JF, Smith BP, et al. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop 2000;20:108-15.
12. Graham HK, Aoki KR, Autti-Ramo I, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000;11:67-79.
13. Naumann M, Hamm H, Kinkelin I, et al. Botulinum toxin type A in the treatment of focal, axillary and palmar hyperhidrosis and other hyperhidrotic conditions. Eur J Neurol 1999;6(suppl4):S111-15.